Zhou, Hongyu <br/><br/>
Updates of mTOR inhibitors.  [electronic resource] 

 -  Anti-cancer agents in medicinal chemistry  Sep 2010 
 - 571-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1875-5992 
<br/><br/><label>Standard No.: </label>10.2174/187152010793498663  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--chemistry<br/>Biological Products--pharmacology<br/>Cell Cycle--drug effects<br/>Cell Proliferation--drug effects<br/>Clinical Trials as Topic<br/>Humans<br/>Neoplasms--drug therapy<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Protein Kinase Inhibitors--chemistry<br/>Protein Kinases--metabolism<br/>Signal Transduction--drug effects<br/>Sirolimus--analogs & derivatives<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Transcription Factors--antagonists & inhibitors